Invest Into AccelPharma

About

AccelPharma is a US-based oncology/potent product manufacturing company building capacity in Valdosta, Georgia.

The team comprises subject matter experts with know-how to develop and operate a Pharmaceutical Contract Manufacturing facility and deliver life-saving oncology medicines from formulations currently on global shortage lists. These formulations are the most difficult to produce and are classified as highest-level potency drugs, requiring very special conditions for production.

scientists
0+
Injectables products on shortage lists
$0 bn
Value of injectables patents expiring in US within 5 yrs
0 mm
To be invested into state-of-the-art sterile facility
Est.0%
Market share shift by 2024 to outsourced production
0%
5yr historical growth rate
for injectables CMOs
Summary
Summary
  • Addressable Market
    $70 billion global generic injectables Contract Manufacturing Outsourcing (CMO), where the largest segment of addressable market has grown by average 15.7% over last 5 years
  • Technology
    State-of-the-art “Isolator” technology allows commercial production of the highest complexity, highest potency “OEB5” products. Modular construction technologies speed up the buildout process, in compliance with jurisdictional certification requirements
  • Future Product Lines
    1) Lyophilized oncology product for US/EU market (commercial production can start in July 2022);
    2) Liquid solution oncology product for US/EU market (commercial production can start March 2022);
  • Facility Construction
    Pre-fabricated clean rooms and pre-engineered steel building frame combine to reduce infrastructure planning and improve reliability of delivery, precision of equipment integration, and time to market
doctor examining the analysis
biotechnology laboratory with workers
  • Pricing
    Commercial production at AccelPharma's facility for EU and US markets will yield substantial cost advantages and value-add benefits
  • R&D Roadmap
    Extend platform to include mix of high-volume and high-margin products, generic and novel products, lyophilized and solution products for use in US, Asia, and EU markets
  • Management
    Operations team has developed 3 pharma CMO facilities over the last 10 years: two successful M&A exits, and one currently operating in China
  • Manufacturing
    Modern, sophisticated, flexible and fully integrated sterile manufacturing complex; meets US regulatory requirements with up to 60mm vials/year production capacity.

Project Controls

Our team of international project controls experts work with our clients to align project expectations with the project goals, which results in better decisions and higer returns on investment.

Planning and Scheduling
lyophilizing Process Read more
Cost Engineering
Water System Read more
Project Estimating
Capping Process Read more
Earned Value Management
lyophilizing Process Read more
Change Management
Water System Read more
Risk Management
Capping Process Read more
Team

Team

Executive Leadership
Dr. Matthew Spear
Chairman of the Board of Directors
Col John Redfearn III (USA Ret)
Member of the Board of Directors
Gen James Comstock, USA (Ret)
Director of Non-GMP Local Extrenal Affairs
Colin Breeze
Member of the Board of Directors
Mark Taylor
Director of Engineering & Project Management
Roman Bachamp
Director of Building Services
Oleksandr Zabudkin
CEO
Julian Aleksov
COO
Alexander Weismann
Ph.D. Strategic Advisor
Vladimír Mat’ha, Ph.D.
COO
Valentí Božilov
Director of Business Development
Yoav Grinberg
Head of Strategic Relations and Partnerships

Planning and Scheduling


Project planning is a collaborative process, and requires constant communication between our team and the project stakeholders. To ensure success, it is imperative to that all stakeholders commit to the initial plan, participate in regular reviews, and recognize that adjustments to approaches may be necessary during the course of the project.


Our project planners develop project schedules that adhere to project timing requirements and provide a critical path to project completion. Our planners optimize the sequence of activities required to design, procure, construct and commission the project - ensuring projects are delivered on time and on budget.

Cost Engineering


We are committed to measuring and controlling total project costs. Our project controls team applies a set of proprietary principles and processes to every project to ensure the cost management through the entire life cycle of the project.

Project Estimating


Our comprehensive, cross functional estimating team leverages extensive project experience and our proprietary cost estimating database to produce cost-effective investment capital budgets and reliable cost forecasts. Our proven estimating methodology provides accurate forecasts throughout the entire project life cycle.

Earned Value Management


Our Earned Value Management System allow the project manager to understand the project's baseline (budget) value of the work to be completed, the actual value of the work completed, and the earned value of the physical work. In addition to Earned Value Management, our expert utilize Project Execution Plans, Project Controls, and Work Plans to assure efficient total project management.

Change Management


The potential for change exists on all projects. Proper change management requires strong, experienced leadership with the support of sound, time-tested processes and systems. We provide a consistent approach to change management that is grounded in our industry leading project delivery system.


Our consistent approach to change management provides the following benefits to our clients:

Risk Management


We follow the Project Management Institute (PMI®) model of risk management, which includes the following five processes:

Cooperate with Us

Cooperate with Us

Please do not hesitate to contact us with any inquiries

map
Head Office
AccelPharma, LLC
c/o 853 Camino Del Mar #201
Del Mar, CA 92014
Email: info@accelpharma.us
Manufacturing Facility
AccelPharma, LLC
Valdosta Opportunity Zone
Valdosta, GA
Email: info@accelpharma.us